One of these goes under your skin and the other never breaks it. Endolift passes a thin optical fibre beneath the skin through a needle entry point and heats tissue from the inside out. Ultherapy focuses ultrasound through skin that stays intact, to a point underneath it.
The regulatory difference is the most important fact on this page, and it is easy to state wrongly. The laser platform used for Endolift, the Eufoton LASEmaR 1500, genuinely does hold FDA clearance (K260489, 29 May 2026). But read what it is cleared for: surgical applications requiring vaporisation, incision, excision, ablation, cutting and hemostasis or coagulation, plus laser-assisted lipolysis. Skin tightening, skin laxity and lifting appear nowhere in that text, and a search of the FDA clearance database for the device name "Endolift" returns no matches. So "Endolift is FDA cleared" is half true: the laser is cleared, the marketed use is not.
Ultherapy's authorisation names lifting outright. It was granted through a De Novo request (DEN080006, 11 September 2009), and its current wording is to lift the eyebrow, lift lax submental and neck tissue, and improve lines and wrinkles of the décolleté. A February 2025 clearance (K243035) added skin laxity on the abdomen and the front and back of the arms. Note what that does and does not mean: an authorisation is permission to market, not a finding that the treatment works well for you.
Endolift is mostly performed outside the United States. Where it is performed in the US, it is off-label use of a cleared surgical laser. Off-label treatment is legal and routine in medicine. It simply means no regulator reviewed this device for this purpose.
A micro-optical fibre is threaded under the skin and drawn through the plane just beneath it.
Nothing enters the skin. The device is held against the surface.
That wavelength is strongly absorbed by water and, to a degree, fat, so energy is deposited over a very short distance around the fibre tip. The result is localised heating, small-volume fat reduction, and thermal contraction of the fibrous bands and the underside of the dermis.
At the focal point tissue reaches coagulative temperatures of roughly 60 to 70 degrees Celsius, creating small columns of denatured collagen. The epidermis and everything between the transducer and the focus are spared. Healing contracts those points over the following two to six months.
The subdermal and superficial subcutaneous layer.
Ultherapy transducers are named by frequency and focal depth: 10-1.5, 7-3.0 and 4-4.5, giving focal depths in the superficial dermis, deep dermis and the superficial musculoaponeurotic layer, the SMAS.
The full cleared text of K260489 covers vaporisation, incision, excision, ablation, cutting, hemostasis or coagulation, and laser-assisted lipolysis, across plastic and aesthetic medicine, ENT, gynaecology and neurosurgery. No lifting or laxity wording exists in it.
Those are the actual cleared words.
Performed under local anaesthetic. This is the conventional clinical description of the procedure, not a figure from an FDA document or a published trial, and there is no US labelling for this use to check it against.
Also not a labelled figure. It is not stated in the Indications for Use.
This is the sentence worth carrying away: the laser is cleared, the marketed use is not.
Eufoton holds two US clearances (K092860 in 2010 and K260489 in 2026), both under the general surgical laser product code. The 2026 clearance describes a 1470 nm diode laser running at a maximum of 15 W. Its Indications for Use are a surgical list plus laser-assisted lipolysis.
Non-surgical facial lifting and skin tightening, which is what Endolift is marketed for, is not in that list. If a US clinic advertises "FDA-cleared Endolift", the reasonable response is to ask for the clearance number and read what it says. Treat the claim as marketing until a number is produced.
Ultherapy delivers energy through intact skin to a focal point. That means no wound, no entry mark, and no infection route. It also means it cannot remove fat, cannot treat surface texture or scarring, and cannot have anything applied through a channel into the skin.
Endolift works in the opposite direction, from a fibre placed in the tissue. That gives it a small fat-reduction capability that a surface device does not have. It also makes it a procedure done through the skin, with everything that implies.
No clinical trial of Endolift was found in the published literature, so nothing here should be read as a statement about how well it performs. What can be said is what is documented: the mechanism, and the regulatory position.
If you get cold sores, say so when you book, not on the day. Antiviral medicine is started in advance, so it has to be prescribed before the appointment. There is no published data on cold-sore reactivation after either of these treatments specifically. The precaution is carried over from laser resurfacing, where reactivation is well documented and antiviral cover is standard practice.
For Endolift, also ask who is performing it and where, since it is done through the skin under local anaesthetic rather than on the surface. Ask what the entry points will be and how many.
Endolift breaks the skin, so infection is a real possibility. Seek urgent care if you develop: